"It's partly about explaining to patients why antibiotics won't help".
ZIMBABWE will this week join the rest of the world in commemorating World Antibiotic Awareness Week to raise awareness on the need to preserve available antibiotics and responsible use of the drugs to avoid antimicrobial resistance (AMR).
Soko adds that antibiotic resistant infections often result in increased length of hospital stay, medical costs and mortality.
The research comes on the back of Public Health England's (PHE) recent 'Keep Antibiotics Working' campaign, aimed at stopping a potential "post-antibiotic apocalypse" caused by too many diseases gaining resistance.
"I'd urge healthcare professionals and residents to make the pledge and become an antibiotic guardian, and for people to think twice about taking antibiotics unless they have specifically been prescribed them by their GP".
The issue is a concern to health agencies around the world as growing numbers of infections - such as pneumonia, tuberculosis, gonorrhoea, and salmonella - are becoming harder to treat as the antibiotics used to treat them become less effective.More news: West Bengal Wins The Battle For Rosogolla
"The need for antibiotic use can further be reduced by ensuring that all vaccinations are up to date".
Imperial College Healthcare NHS Trust is also holding an antibiotics amnesty this month.
"Scientific evidence demonstrates that overuse of antibiotics in animals can contribute to the emergence of antibiotic resistance", says Dr Kazuaki Miyagishima, Director of the Department of Food Safety and Zoonoses at WHO.
BEVA is a consistent campaigner for the responsible use of antibiotics; past year it introduced the BEVA Antibiotic Champion Award to encourage members to document their efforts to reduce the use of critically important antibiotics.
"We are misusing antibiotics by using them when it is not needed (for the common cold or viral infection), not completing the prescribed dose and using them to promote growth and productivity in agriculture", Stegelmeier said.
Among the WHO's the highest priority antibiotics are quinolones, 3rd and higher generation cephalosporins, macrolides and ketolides, glycopeptides and polymyxins (also known as colistin).